{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:04:04Z","timestamp":1775570644087,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Parenteral artesunate is the treatment of choice for severe malaria. It is safe, efficacious and well tolerated anti-malarial. However, delayed haemolysis has been reported in travellers, non-immune individuals and in African children.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A prospective, observational study was carried out in admitted severe malaria patients receiving parenteral artesunate. The patients were followed up until day 28 for monitoring clinical as well as laboratory parameters for haemolytic anaemia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty-four patients with severe malaria receiving injection artesunate were enrolled in the study. Post-artesunate delayed haemolysis following parenteral artesunate therapy was observed in three of 24 patients (12.5%, 95% confidence interval 4.5\u201331.2%). Haemolysis was observed in two more patients possibly due to other reasons. The haemoglobin fall ranged from 13.6 to 38.3% from day 7 to day 28 in these patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The possibility of delayed haemolysis should be considered while treating the severe malaria patients with parenteral artesunate. The study highlights the need for further studies in different epidemiological settings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12936-020-3120-4","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T15:02:41Z","timestamp":1579705361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India"],"prefix":"10.1186","volume":"19","author":[{"given":"Deepali","family":"Savargaonkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeevan K.","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bina","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupkumar R.","family":"Anvikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Valecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"3120_CR1","unstructured":"WHO. Fact sheets malaria. Geneva: World Health Organization; 2019. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/malaria. Accessed 20 Sept 2019."},{"key":"3120_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/tmi.12313_2","volume":"19","author":"WHO","year":"2014","unstructured":"WHO. Severe Malaria Section\u00a01: epidemiology of severe falciparum malaria. Trop Med Int Health. 2014;19:7\u2013131.","journal-title":"Trop Med Int Health"},{"key":"3120_CR3","unstructured":"WHO. World malaria report 2018. Geneva: World Health Organization; 2018. https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/en\/. Accessed 22 Sept 2019."},{"key":"3120_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4269\/ajtmh.2009.80.194","volume":"80","author":"DK Kochar","year":"2009","unstructured":"Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009;80:194\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"3120_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12098-011-0603-x","volume":"79","author":"D Yadav","year":"2012","unstructured":"Yadav D, Chandra J, Aneja S, Kumar V, Kumar P, Dutta AK. Changing profile of severe malaria in north Indian children. Indian J Pediatr. 2012;79:483\u20137.","journal-title":"Indian J Pediatr"},{"key":"3120_CR6","unstructured":"WHO. Guidelines for the treatment of malaria, 2nd edn. Geneva: World Health Organization; 2010. p. 210. http:\/\/apps.who.int\/medicinedocs\/en\/m\/abstract\/Js19105en\/. Accessed 20 Sept 2019."},{"key":"3120_CR7","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","volume":"376","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376:1647\u201357.","journal-title":"Lancet"},{"key":"3120_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","volume":"366","author":"AM Dondorp","year":"2005","unstructured":"Dondorp AM. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366:717\u201325.","journal-title":"Lancet"},{"key":"3120_CR9","first-page":"CD005967","volume":"6","author":"D Sinclair","year":"2012","unstructured":"Sinclair D, Donegan S, Isba R, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012;6:CD005967.","journal-title":"Cochrane Database Syst Rev."},{"key":"3120_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3201\/eid1705.101229","volume":"17","author":"T Zoller","year":"2011","unstructured":"Zoller T, Junghanss T, Kapaun A, Gj\u00f8rup I, Richter J, Hugo-Persson M, et al. Intravenous artesunate for severe malaria in travelers, europe. Emerg Infect Dis. 2011;17:771\u20137.","journal-title":"Emerg Infect Dis"},{"key":"3120_CR11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3201\/eid2105.141171","volume":"21","author":"S Jaur\u00e9guiberry","year":"2015","unstructured":"Jaur\u00e9guiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, et al. Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011\u20132013. Emerg Infect Dis. 2015;21:804\u201312.","journal-title":"Emerg Infect Dis"},{"key":"3120_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.4269\/ajtmh.14-0149","volume":"91","author":"C Burri","year":"2014","unstructured":"Burri C, Ferrari G, Ntuku HM, Kitoto AT, Duparc S, Hugo P, et al. Delayed anemia after treatment with injectable artesunate in the Democratic Republic of the Congo: a manageable issue. Am J Trop Med Hyg. 2014;91:821\u20133.","journal-title":"Am J Trop Med Hyg"},{"key":"3120_CR13","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/infdis\/jit841","volume":"209","author":"T Rolling","year":"2014","unstructured":"Rolling T, Agbenyega T, Issifou S, Adegnika AA, Sylverken J, Spahlinger D, et al. Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria\u2014a double-center prospective study. J Infect Dis. 2014;209:1921\u20138.","journal-title":"J Infect Dis"},{"key":"3120_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1475-2875-12-241","volume":"12","author":"T Rolling","year":"2013","unstructured":"Rolling T, Wichmann D, Schmiedel S, Burchard GD, Kluge S, Cramer JP. Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis. Malar J. 2013;12:241.","journal-title":"Malar J."},{"key":"3120_CR15","unstructured":"WHO. Information note on delayed haemolytic anaemia following treatment with artesunate. Geneva: World Health Organization; 2013. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547925_eng.pdf. Accessed 20 Sept 2019."},{"key":"3120_CR16","unstructured":"WHO. Guidelines for the treatment of malaria, 3rd edn. Geneva: World Health Organization; 2015. p. 318. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/162441\/9789241549127_eng.pdf;jsessionid=0AB6AFAD9A83177820E657FEDDFEA1FE?sequence=1. Accessed 20 Sept 2019."},{"key":"3120_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/S2221-1691(13)60119-7","volume":"3","author":"P Wilairatana","year":"2013","unstructured":"Wilairatana P, Tangpukdee N, Krudsood S. Definition of hyperparasitemia in severe falciparum malaria should be updated. Asian Pac J Trop Biomed. 2013;3:586.","journal-title":"Asian Pac J Trop Biomed."},{"key":"3120_CR18","first-page":"1082","volume":"33","author":"GA Daland","year":"1948","unstructured":"Daland GA, Castle WB. A simple and rapid method for demonstrating sickling of the red blood cells; the use of reducing agents. J Lab Clin Med. 1948;33:1082\u20138.","journal-title":"J Lab Clin Med"},{"key":"3120_CR19","unstructured":"National Vector Borne Disease Control Programme. National drug policy on malaria; 2013. http:\/\/www.nvbdcp.gov.in\/Doc\/National-Drug-Policy-2013.pdf. Accessed 20 Sept 2019."},{"key":"3120_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tmaid.2016.10.013","volume":"15","author":"T Ald\u00e1miz-Echevarr\u00eda Lois","year":"2017","unstructured":"Ald\u00e1miz-Echevarr\u00eda Lois T, L\u00f3pez-Pol\u00edn A, Norman FF, Monge-Maillo B, L\u00f3pez-V\u00e9lez R, Perez-Molina JA. Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: report on the experience of a referral centre for tropical infections in Spain. Travel Med Infect Dis. 2017;15:52\u20136.","journal-title":"Travel Med Infect Dis."},{"key":"3120_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1475-2875-11-102","volume":"11","author":"AR Kreeftmeijer-Vegter","year":"2012","unstructured":"Kreeftmeijer-Vegter AR, Van Genderen PJ, Visser LG, Bierman WFW, Clerinx J, Van Veldhuizen CKW, et al. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J. 2012;11:102.","journal-title":"Malar J."},{"key":"3120_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12879-017-2678-0","volume":"17","author":"C Fanello","year":"2017","unstructured":"Fanello C, Onyamboko M, Lee SJ, Woodrow C, Setaphan S, Chotivanich K, et al. Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine. BMC Infect Dis. 2017;17:575.","journal-title":"BMC Infect Dis"},{"key":"3120_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4103\/ijccm.IJCCM_298_18","volume":"22","author":"S Singh","year":"2018","unstructured":"Singh S, Singh SK, Tentu AK, Kumar A, Shahbabu B, Singh VSN. Artesunate-induced severe autoimmune hemolytic anemia in complicated malaria. Indian J Crit Care Med. 2018;22:753\u20136.","journal-title":"Indian J Crit Care Med."},{"key":"3120_CR24","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3201\/eid2208.151905","volume":"22","author":"F Kurth","year":"2016","unstructured":"Kurth F, Lingscheid T, Steiner F, Stegemann MS, B\u00e9lard S, Menner N, et al. Hemolysis after oral artemisinin combination therapy for uncomplicated Plasmodium falciparum malaria. Emerg Infect Dis. 2016;22:1381\u20136.","journal-title":"Emerg Infect Dis"},{"key":"3120_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0140-6736(13)60812-0","volume":"382","author":"JN Jarvis","year":"2013","unstructured":"Jarvis JN, Coltart CE, Pule M, Chiodini PL, Doherty T. Artemisinin therapy and severe delayed haemolysis. Lancet. 2013;382:180.","journal-title":"Lancet"},{"key":"3120_CR26","doi-asserted-by":"publisher","first-page":"tax091","DOI":"10.1093\/jtm\/tax091","volume":"25","author":"D Lebrun","year":"2018","unstructured":"Lebrun D, Floch T, Brunet A, Julien G, Romaru J, N\u2019Guyen Y, et al. Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report. J Travel Med. 2018;25:tax091.","journal-title":"J Travel Med."},{"key":"3120_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/1475-2875-13-398","volume":"13","author":"L Raffray","year":"2014","unstructured":"Raffray L, Receveur MC, Beguet M, Lauroua P, Pistone T, Malvy D. Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report. Malar J. 2014;13:398.","journal-title":"Malar J."},{"key":"3120_CR28","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1182\/blood.V90.5.2037","volume":"90","author":"BJ Angus","year":"1997","unstructured":"Angus BJ, Chotivanich K, Udomsangpetch R, White NJ. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood. 1997;90:2037\u201340.","journal-title":"Blood"},{"key":"3120_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2014-02-555953","volume":"124","author":"S Jaur\u00e9guiberry","year":"2014","unstructured":"Jaur\u00e9guiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, et al. Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood. 2014;124:167\u201375.","journal-title":"Blood"},{"key":"3120_CR30","first-page":"1","volume-title":"Experts Group Meeting on delayed haemolytic anaemia following treatment with injectable artesunate","author":"MMV","year":"2013","unstructured":"MMV. Experts Group Meeting on delayed haemolytic anaemia following treatment with injectable artesunate. Geneva: MMV; 2013. p. 1\u201327."},{"key":"3120_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0010038","volume":"5","author":"R Fendel","year":"2010","unstructured":"Fendel R, Brandts C, Rudat A, Kreidenweiss A, Steur C, Appelmann I, et al. Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia. PLoS ONE. 2010;5:1\u20138.","journal-title":"PLoS ONE"},{"key":"3120_CR32","first-page":"1","volume":"145","author":"O Boillat","year":"2015","unstructured":"Boillat O, Spechbach H, Chalandon Y, Eperon G. Post-artesunate delayed haemolysis\u2014report of four cases and review of the literature. Swiss Med Wkly. 2015;145:1\u20137.","journal-title":"Swiss Med Wkly."},{"key":"3120_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12936-015-0760-x","volume":"14","author":"K Plewes","year":"2015","unstructured":"Plewes K, Haider MS, Kingston HWF, Yeo TW, Ghose A, Hossain MA, et al. Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury. Malar J. 2015;14:246.","journal-title":"Malar J."},{"key":"3120_CR34","first-page":"581","volume":"39","author":"W Leowattana","year":"2008","unstructured":"Leowattana W, Krudsood S, Tangpukdee N, Brittenham G, Looareesuwan S. Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia. Southeast Asian J Trop Med Public Health. 2008;39:581\u20138.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"3120_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12879-015-1285-1","volume":"15","author":"K Plewes","year":"2015","unstructured":"Plewes K, Maude RJ, Ghose A, Dondorp AM. Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report. BMC Infect Dis. 2015;15:555.","journal-title":"BMC Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-3120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-020-3120-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-3120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:18:08Z","timestamp":1611188288000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-3120-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-3120-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"28 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional ethics committees of National Institute of Malaria Research, New Delhi and Rajendra Institute of Medical Sciences, Ranchi. Written informed consent\/assent along with guardian\u2019s consent was obtained from patients for participation in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}